Stay updated on aRCH With Cisplatin ± Pembrolizumab in HNSCC Clinical Trial

Sign up to get notified when there's something new on the aRCH With Cisplatin ± Pembrolizumab in HNSCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the aRCH With Cisplatin ± Pembrolizumab in HNSCC Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    The page footer revision label was updated from v3.3.1 to v3.3.2. There are no changes to the study details or navigation.
    Difference
    0.1%
    Check dated 2025-12-01T16:29:28.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Revision updated from v3.2.0 to v3.3.1; no trial content or eligibility criteria appear to be affected.
    Difference
    0.1%
    Check dated 2025-11-24T10:55:22.000Z thumbnail image
  4. Check
    29 days ago
    Change Detected
    Summary
    The notice about government funding status and NIH operating status has been removed from the page. The core study details, eligibility criteria, and study plan remain unchanged.
    Difference
    0.4%
    Check dated 2025-11-17T06:03:20.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    The new screenshot appears to show cosmetic UI/layout adjustments and minor wording tweaks, with no alterations to core study data such as trial arms, eligibility criteria, endpoints, or enrollment numbers. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-02T22:55:20.000Z thumbnail image
  6. Check
    72 days ago
    Change Detected
    Summary
    Updated version to v3.2.0 and added a government-operating-status notice; removed the prior v3.1.0 tag.
    Difference
    4%
    Check dated 2025-10-05T05:11:53.000Z thumbnail image
  7. Check
    79 days ago
    Change Detected
    Summary
    Version updated from v3.0.2 to v3.1.0; no substantive content changes detected.
    Difference
    0.1%
    Check dated 2025-09-28T02:50:25.000Z thumbnail image

Stay in the know with updates to aRCH With Cisplatin ± Pembrolizumab in HNSCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the aRCH With Cisplatin ± Pembrolizumab in HNSCC Clinical Trial page.